News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
38,693 Results
Type
Article (2468)
Company Profile (40)
Press Release (36185)
Multimedia
Podcasts (4)
Webinars (2)
Section
Business (14148)
Career Advice (79)
Deals (2083)
Drug Delivery (9)
Drug Development (4114)
Employer Resources (10)
FDA (433)
Job Trends (769)
News (20176)
Policy (1053)
Tag
Academia (145)
Allergies (6)
Alliances (3483)
ALS (4)
Alzheimer's disease (49)
Antibody-drug conjugate (ADC) (20)
Approvals (434)
Artificial intelligence (13)
Autoimmune disease (3)
Automation (1)
Bankruptcy (12)
Best Places to Work (475)
BIOSECURE Act (2)
Biosimilars (12)
Biotechnology (30)
Bladder cancer (7)
Brain cancer (5)
Breast cancer (22)
Cancer (177)
Cardiovascular disease (5)
Career advice (64)
Career pathing (1)
CAR-T (18)
Cell therapy (52)
Cervical cancer (2)
Clinical research (3233)
Collaboration (112)
Company closure (1)
Compensation (59)
COVID-19 (182)
CRISPR (9)
C-suite (37)
Cystic fibrosis (2)
Data (167)
Denatured (3)
Depression (5)
Diabetes (12)
Diagnostics (468)
Digital health (1)
Diversity, equity & inclusion (1)
Drug discovery (15)
Drug pricing (8)
Duchenne muscular dystrophy (16)
Earnings (4322)
Editorial (3)
Employer branding (1)
Employer resources (8)
Events (6140)
Executive appointments (110)
FDA (493)
Funding (94)
Gene editing (18)
Gene therapy (26)
GLP-1 (60)
Government (149)
Guidances (8)
Healthcare (705)
Huntington's disease (3)
IgA nephropathy (7)
Immunology and inflammation (20)
Immuno-oncology (1)
Indications (2)
Infectious disease (189)
Inflammatory bowel disease (11)
Inflation Reduction Act (6)
Influenza (6)
Intellectual property (12)
Interviews (7)
IPO (999)
IRA (7)
Job creations (290)
Job search strategy (62)
Kidney cancer (6)
Labor market (6)
Layoffs (41)
Leadership (1)
Legal (213)
Liver cancer (6)
Lung cancer (17)
Lymphoma (5)
Management (4)
Manufacturing (24)
MASH (5)
Medical device (308)
Medtech (308)
Mergers & acquisitions (1168)
Metabolic disorders (38)
Multiple sclerosis (11)
Neurodegenerative disease (13)
Neuropsychiatric disorders (3)
Neuroscience (106)
NextGen: Class of 2025 (353)
Non-profit (153)
Now hiring (6)
Obesity (17)
Opinion (15)
Ovarian cancer (11)
Pain (13)
Pancreatic cancer (7)
Parkinson's disease (4)
Partnered (2)
Patents (27)
Patient recruitment (5)
Peanut (1)
People (5708)
Pharmaceutical (5)
Phase I (1392)
Phase II (1619)
Phase III (863)
Pipeline (111)
Policy (14)
Postmarket research (30)
Preclinical (607)
Press Release (2)
Prostate cancer (4)
Psychedelics (2)
Radiopharmaceuticals (13)
Rare diseases (25)
Real estate (421)
Recruiting (5)
Regulatory (815)
Reports (7)
Research institute (143)
Resumes & cover letters (9)
RNA editing (2)
Schizophrenia (14)
Series A (29)
Series B (9)
Service/supplier (2)
Sickle cell disease (1)
Special edition (3)
Spinal muscular atrophy (2)
Sponsored (1)
Startups (491)
Stomach cancer (1)
Supply chain (4)
The Weekly (1)
Vaccines (31)
Venture capitalists (8)
Weight loss (12)
Women's health (1)
Worklife (1)
Date
Last 7 days (40)
Last 30 days (171)
Last 365 days (2460)
2025 (1217)
2024 (2613)
2023 (2873)
2022 (3762)
2021 (4050)
2020 (3475)
2019 (2062)
2018 (1554)
2017 (1795)
2016 (1624)
2015 (1833)
2014 (1369)
2013 (1188)
2012 (1396)
2011 (1332)
2010 (1181)
Location
Africa (43)
Alabama (2)
Arizona (15)
Asia (1890)
Australia (298)
California (1037)
Canada (160)
China (46)
Colorado (24)
Connecticut (11)
Delaware (4)
Europe (3871)
Florida (48)
Georgia (8)
Idaho (3)
Illinois (16)
India (1)
Indiana (36)
Japan (11)
Kansas (12)
Kentucky (1)
Maryland (30)
Massachusetts (364)
Michigan (10)
Minnesota (17)
Mississippi (1)
Missouri (3)
Nebraska (1)
Nevada (3)
New Hampshire (2)
New Jersey (81)
New York (58)
North Carolina (98)
Northern California (451)
Ohio (28)
Oklahoma (2)
Oregon (5)
Pennsylvania (66)
Rhode Island (2)
South America (40)
South Carolina (1)
Southern California (435)
Tennessee (3)
Texas (89)
United States (2093)
Utah (2)
Virginia (7)
Washington D.C. (1)
Washington State (59)
West Virginia (1)
Wisconsin (6)
38,693 Results for "annexon biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Annexon Biosciences to Present at the Jefferies Global Healthcare Conference
May 29, 2025
·
1 min read
Neuroscience
Annexon Touts ‘Rapid’ and ‘Durable’ Improvements for Targeted Guillain-Barré Therapy
Jefferies analysts predict Annexon’s tanruprubart could be approved by mid-2026.
April 10, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Annexon Biosciences to Present at the TD Cowen 45th Annual Health Care Conference
February 26, 2025
·
1 min read
Press Releases
Annexon Reports Inducement Grants to 2 New Employees Under Nasdaq Listing Rule 5635(c)(4)
May 16, 2025
·
1 min read
Press Releases
Annexon Biosciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference
January 8, 2025
·
1 min read
Press Releases
Annexon Reports First Quarter 2025 Financial Results, Portfolio Progress and Key Anticipated Milestones
May 12, 2025
·
12 min read
Press Releases
Annexon to Present on the Neuroprotective Effects of ANX007 at the 2025 ARVO Annual Meeting and the Retina World Congress
May 8, 2025
·
9 min read
Press Releases
Annexon Biosciences to Present at the 2024 Jefferies London Healthcare Conference
November 14, 2024
·
1 min read
Press Releases
Annexon Announces Presentations on the Clinical Advancement of Tanruprubart as the First Potential Targeted Therapy for Guillain-Barré Syndrome (GBS) at the 2025 PNS Meeting
May 12, 2025
·
6 min read
Press Releases
Annexon Showcases Tanruprubart Data Demonstrating Improved Clinical Outcomes in Guillain-Barré Syndrome (GBS) at 2025 Peripheral Nerve Society (PNS) Annual Meeting
May 20, 2025
·
8 min read
1 of 3,870
Next
